The Sanskara Platform

A Table To Help Manage ECS

Understanding the Endocannabinoid System

Introduction

The endocannabinoid system (ECS) plays a crucial role in maintaining balance and homeostasis within our bodies. It consists of a complex network of receptors, endocannabinoids, and enzymes that interact with cannabinoids found in cannabis plants. For medical cannabis patients in the UK, understanding the ECS is essential for maximising the therapeutic benefits of cannabis-based treatments. In this article, we will delve into the intricacies of the endocannabinoid system, its functions, and how it relates to medical cannabis.

The Endocannabinoid System: An Overview

The ECS is composed of three primary components: endocannabinoid receptors, endocannabinoids, and enzymes. The two main receptors within the ECS are CB1 and CB2 receptors. CB1 receptors are primarily found in the central nervous system, while CB2 receptors are predominantly located in the immune system and peripheral tissues. Endocannabinoids, such as anandamide and 2-arachidonoylglycerol (2-AG), are naturally occurring compounds produced within our bodies that bind to these receptors. Enzymes, specifically fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL), break down endocannabinoids once their purpose is served.

Functions of the Endocannabinoid System

The ECS plays a vital role in regulating numerous physiological processes, including:

a. Pain and Inflammation: Activation of CB1 receptors in the central nervous system can help modulate pain perception, while CB2 receptors in the immune system regulate inflammation and immune responses.

b. Mood and Stress: The ECS influences mood regulation by interacting with neurotransmitter systems. Activation of CB1 receptors has been associated with the alleviation of anxiety and depression symptoms.

c. Sleep and Appetite: The ECS is involved in the regulation of sleep-wake cycles and appetite. CB1 receptors in the hypothalamus and limbic system influence food intake and energy balance.

d. Memory and Learning: The ECS is implicated in memory formation and neuroplasticity. CB1 receptors in the hippocampus and cerebral cortex contribute to these cognitive functions.

Medical Cannabis and the Endocannabinoid System

Medical cannabis, containing cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD), interacts with the ECS to exert its therapeutic effects. THC binds to CB1 receptors, producing psychoactive effects and influencing pain perception, appetite, and mood. CBD, on the other hand, has a low affinity for both CB1 and CB2 receptors but modulates the ECS indirectly by interacting with other receptor systems. CBD has shown promise in reducing seizures, managing pain and inflammation, and aiding with anxiety and sleep disorders.

Optimising Medical Cannabis Use in the UK

For medical cannabis patients in the UK, optimising the use of cannabis-based treatments involves several key considerations:

a. Strain Selection: Different cannabis strains contain varying ratios of cannabinoids and terpenes, each with unique therapeutic properties. Working with a healthcare professional or pharmacist experienced in medical cannabis can help identify the most suitable strains for individual conditions.

b. Dosage and Administration: Accurate dosing is essential to achieve desired therapeutic effects while minimising side effects. Patients should start with low doses and gradually increase until they find their optimal dosage. Various administration methods, such as inhalation, oral ingestion, and topical application, offer different onset times and durations.

c. Monitoring and Adjusting: Regular monitoring of symptoms and side effects is crucial to evaluating treatment efficacy. Adjustments to dosage, strain, or administration method may be necessary to optimise therapeutic outcomes.

A Table To Help Manage ECS

Optimising Your Endocannabinoid System (ECS): A Comprehensive Guide on Evidence-Based Interventions →

Conclusion

Understanding the endocannabinoid system is fundamental for medical cannabis patients in the UK seeking effective relief from various conditions. By comprehending how the ECS functions and interacts with cannabinoids, patients can make informed decisions about strain selection, dosing, and administration methods. Additionally, working closely with healthcare professionals ensures safe and personalised treatment plans. The evolving landscape of medical cannabis research may further enhance our knowledge of the ECS and unlock new possibilities for therapeutic interventions in the future.

References:

  1. Pacher, P., & Kunos, G. (2013). Modulating the endocannabinoid system in human health and disease: successes and failures. The FEBS Journal, 280(9), 1918–1943.
  2. Pertwee, R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. British Journal of Pharmacology, 153(2), 199–215.
  3. Russo, E. B. (2008). Cannabinoids in the management of difficult to treat pain. Therapeutics and Clinical Risk Management, 4(1), 245–259.
  4. Zuardi, A. W. (2008). Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Revista Brasileira de Psiquiatria, 30(3), 271–280.

More Cannabis Science

Learn More

Understanding the Endocannabinoid System Read More »

Unveiling the Rich History of Cannabis in China

UNVEILING THE RICH HISTORY OF CANNABIS IN CHINA

Introduction

Dive into the captivating world of cannabis as we embark on a historical journey through China’s profound relationship with this remarkable plant. In this extensively researched blog post, we explore the multifaceted history of cannabis in China. From ancient origins to its resurgence in modern medicine, we uncover its cultural significance, medicinal applications, and the evolving landscape surrounding its use.

Ancient Origins: A Legacy Rooted in Tradition

Cannabis cultivation in China dates back thousands of years, with archeological evidence suggesting its use as early as the Neolithic period. The plant, known as “da ma” (大妈) or “má” (嘛) played a central role in Chinese society. It was cultivated for its versatile fibres, which were transformed into textiles, ropes, and paper, supporting the development of ancient Chinese civilisation.

Historical Medicinal Practices: Honouring the Wisdom of Traditional Chinese Medicine (TCM)

Cannabis holds a revered place in Traditional Chinese Medicine (TCM), a holistic healing system that has been practiced for centuries. Ancient Chinese medical texts, such as the “Shennong Ben Cao Jing” from around 100 AD, document the therapeutic properties of cannabis. It was utilised to address a range of ailments, including pain, inflammation, malaria, and gynaecological disorders, showcasing the extensive knowledge of herbal medicine in ancient China.

Taoist Philosophy: Cannabis as a Path to Spiritual Enlightenment

Taoism, a profound philosophical and religious tradition, embraced the spiritual aspects of cannabis. Within the teachings of Taoist philosophy, cannabis was believed to enhance meditation, perception, and communication with the divine. Notably, the “Baopuzi” (抱朴子) a text authored by Ge Hong during the Jin dynasty, details the ritualistic use of cannabis for transcendent experiences and spiritual enlightenment.

Literature and Art: Cannabis in China as an Inspiration for Creativity

Throughout Chinese history, cannabis found its way into literature and art, serving as a muse for creativity. Esteemed poets, such as Li Bai from the Tang dynasty, celebrated the plant’s intoxicating effects in their works, elevating cannabis as a symbol of transcendence and poetic inspiration. The profound influence of cannabis on Chinese literature is a testament to its cultural significance and enduring allure.

Prohibition and Recent Developments: Navigating Changing Tides

In the 20th century, China implemented strict drug control policies, leading to the prohibition of cannabis. However, recent years have witnessed a renewed focus on cannabis, specifically its medicinal potential. The Chinese government has initiated research and development projects exploring cannabis-based pharmaceuticals, with a particular emphasis on cannabidiol (CBD), a non-psychoactive compound of the plant.

Conclusion:

Delving into the rich history of cannabis in China unveils its enduring significance in various aspects of Chinese culture. From its ancient origins as a versatile resource to its integral role in traditional medicine and spiritual practices, cannabis has left an indelible mark on Chinese society. As medical cannabis patients in the UK, exploring the historical context and cultural significance of cannabis in China can deepen our understanding of this remarkable plant’s potential benefits.

Sources:

1. “Cannabis in Chinese Medicine: Are Some Traditional Indications Referenced in Ancient Literature Related to Cannabinoids?” – Journal of Ethnopharmacology

2. “Cannabis in Chinese Medicine: Are Some Traditional Indications Referenced in Ancient Literature Related to Cannabinoids?” – ResearchGate

3. “Cannabis in Chinese Medicine” – The Botanical Source

4. “The History of Cannabis in China: An Ancient Plant with Many Uses” – The Third Wave

Disclaimer: This blog post is for informational purposes only and should not be considered medical advice. Consult with healthcare professionals before using cannabis for medicinal purposes, and adhere to the regulations and guidelines set by the relevant authorities.

More Educational Posts…

Unveiling the Rich History of Cannabis in China Read More »

The Sanskara Platform 'S' Logo

Support Free Medical Cannabis Education: Join The Sanskara Platform Community!

Welcome to The Sanskara Platform’s Patreon page! We are dedicated to empowering UK patients by providing free education and resources on medical cannabis. Our mission is to ensure that every patient has access to the information they need to make informed decisions about their health.

Through our Patreon page, you can directly support our cause and help us continue providing high-quality content and valuable resources to patients in need. Your patronage will contribute to the maintenance of our website, the creation of educational materials, and the expansion of our outreach efforts.

Join us as we work towards advancing the medical cannabis industry in the UK. By becoming a patron, you not only gain exclusive benefits but also become an integral part of our community of supporters who are passionate about improving patient care and well-being.

Membership:

1. Seedling Supporter – £5 per month:

– Early access to new educational content

– Exclusive behind-the-scenes updates

2. Blossom Advocate – £10 per month:

– All benefits of the Seedling Supporter tier

– Early access to Q&A sessions with medical cannabis experts

– Personalised recommendations for further resources

3. Evergreen Champion – £20 per month:

– All benefits of the Blossom Advocate tier

– Exclusive access to in-depth research articles and case studies

– Invitation to a private online community for discussions and networking

4. Sanskara VIP – £50 per month:

– All benefits of the Evergreen Champion tier

– Personalised 30 min one-on-one support with an experienced patient

– Special recognition as a Sanskara VIP on our website and social media platforms

Your membership support will directly contribute to our ability to provide free resources, maintain our website, and expand our reach to help even more patients. Every tier offers unique benefits, allowing you to engage with our platform and be a part of the positive change we strive for.

Thank you for considering becoming a patron of The Sanskara Platform. Together, we can make a difference in the lives of UK patients seeking medical cannabis education and resources!

Support Free Medical Cannabis Education: Join The Sanskara Platform Community! Read More »

Cannabis Europa Takes Place as the Cannabis Industry Gains Exponential Global Momentum

Europe’s leading cannabis conference returns to London as adult-use cannabis markets accelerate toward legalization

London, United Kingdom, April 3, 2023 – Changing attitudes towards cannabis, economic forces, and heightened sensitivity of social justice issues are just a few of the factors turning the tide of adult-use legalization in Europe. Sales of legal, adult-use cannabis in Europe are forecast to reach €1.6 billion by 2027, as European adult-use markets in Germany, Czech Republic, Switzerland and the Netherlands develop. Over the same period of time, there will be exponential growth of the medical cannabis patient population in countries like France, the UK and Poland, pushing the total number of medical cannabis patients in Europe to an estimated 1.43 million — a 234% increase over the forecast period (2023-2027).

It is amid this backdrop that Cannabis Europa, Europe’s leading cannabis policy event, returns to London on May 2-3, 2023, at the Barbican Centre in London. The annual event will bring together over 1,500 policymakers, industry operators, investors and advocates from over 37 nations to discuss the state of the industry and the global opportunities emerging in the region.

Dorien Rookmaker, MEP for The Netherlands who will appear on the panel “EU Better Believe It,” noted that there are big questions ahead for the industry. “The expanding legalization of the medicinal and recreational use of marijuana has created enormous opportunities worldwide. International standards and improvement of legislation is of high importance. What are the next steps?”

Cannabis Europa will analyze the key drivers of growth for the market, as well as the opportunities and challenges that lie ahead. Chief among them is the timing of legalization across Europe and how regulations will impact the speed and growth of the market.

“Even if it feels slow, Europe is on its way to create a new way of dealing with cannabis – fair, accessible, but still highly regulated,” said Dirk Heitepriem, Deputy Chairman German Cannabis Industry Association, who will speak on the “State of Play Session: Germany.”

The European cannabis market has historically been more stringent than the U.S. in terms of product diversity and access, even for medical use, and that is unlikely to change even as laws surrounding the substance evolve for safety reasons. Even so, the combined sales of CBD, medical and adult-use cannabis will reach almost €6.5 billion by 2027, according to a forthcoming report from Prohibition Partners, the group behind Cannabis Europa.

“Prohibition seems to be failing completely in the cannabis sector and the market has not only settled down but is also growing. That is why we need to find better instruments of control. A strictly regulated market can regulate what is produced where by whom and how much is sold.

A total ban cannot do this,” explains the Czech National Drug Coordinator, Jindrich Voboril. “A regulated market has a higher potential for prevention of harms.”

The two-day agenda will feature a prestigious group of advocates, innovators, policymakers and investors engaging in meaningful conversations about how to drive this market forward. Ticket prices for the conference begin at £420 for the general 2-day conference and expo ticket. VIP tickets are available for £720 and include a networking breakfast the morning of May 2nd and a drinks reception in the beautiful Barbican Conservatory on May 3rd. Upgraded tickets also include access to an exclusive VIP networking lounge and complimentary food and beverage across both days. If you want to obtain tickets at the lowest price, please click here.

About Cannabis Europa

Since 2018, Cannabis Europa has been the premier cannabis event in Europe, drawing over 1,500 attendees from more than 37 countries for two days of industry insights and networking. At this event, participants have a unique chance to connect with influential leaders from successful cannabis companies, investors who are actively investing in the market, and important policymakers. This potent combination of industry expertise, financial acumen, and political influence is precisely what the European cannabis industry needs to progress. To learn more about Cannabis Europa and register for the event, please visit their website at www.cannabis-europa.com.

MEDIA CONTACT

MATTIO Communications

mel@mattio.com

DISCOUNT CODES

We at Sanskara are excited to be attending this event and we are also honoured to be able to offer our community with discount codes for this event. Take part, learn and get involved with the industry.

15Sanskara – 15% Off VIP Tickets

Sanakara10 – 10% Off Standard Tickets

SANSCON – Concession Tickets

Cannabis Europa Takes Place as the Cannabis Industry Gains Exponential Global Momentum Read More »

go pro, pen, notepad-1478810.jpg

Your Guide to Importing Medical Cannabis on Your Next Holiday

Travel Abroad With Medical Cannabis

Are you planning to travel abroad with medical cannabis from the UK? It can be a daunting task to navigate the various regulations and import laws of each destination country. Fortunately, The Sanskara Platform has compiled a comprehensive guide to help you with the process.

The Sanskara Platform is an online resource that provides guidance on medical cannabis for patients, caregivers, and healthcare professionals. They have recently released a new table of information that outlines the regulations for importing medical cannabis into several popular British holiday destinations.

The table provides a detailed breakdown of the import laws and regulations for each country, along with contact information for the relevant embassy departments. This makes it easier for patients to plan their travel and ensure they have the necessary documentation and permissions to bring their medication with them.

It is important to note that each country has its own regulations, and it is essential to consult with the relevant embassy or consulate before travelling. The Sanskara Platform’s guide can serve as a starting point, but it is not a substitute for professional legal advice.

If you are planning to travel abroad from the UK with a medical cannabis prescription, make sure to check out The Sanskara Platform’s table of information. It can be accessed via their website at https://thesanskaraplatform.co.uk/travelling-abroad/.

Medical cannabis is a rapidly growing industry and has proven to be effective in treating various health conditions. However, different countries have varying regulations regarding the importation of medical cannabis. The Sanskara Platform has created a table of information that outlines the necessary details and contact details/links for the importation of medical cannabis into popular British holiday destinations.

Australia, Bahamas, Belgium, Bermuda, Czech Republic, Greece, Hungary, Italy, Jamaica, Netherlands, Romania, Spain, Sweden, Thailand, Trinidad & Tobago, and Turkey are included in the table. Among these countries, Germany, Poland, and Portugal allow for the importation of medical cannabis for personal use with certain conditions.

Germany permits the importation of cannabis for personal use if prescribed by a doctor on the German list of narcotics. The patient is required to complete a form similar to the provided template and obtain confirmation from the supervising health authority of the patient’s county/area of residence. The patient can carry the cannabis for up to 30 days.

In Poland, a patient may bring medicines to the country for personal use not exceeding five smallest packages. However, the patient needs to complete a document for import/export of narcotic drugs/psychotropic substances for medical needs and obtain consent from the Chief Pharmaceutical Inspectorate.

In Portugal, patients can bring a higher amount of medication than required for the stay to anticipate unforeseen events. For medicines containing controlled substances, including cannabis, patients can bring only the amount required for 30 days of treatment with a medical justification/doctor’s statement. Patients are advised to contact the authority responsible for Customs and/or Civil Aviation in their country to find out the necessary documents required to transport medical cannabis.

Greece allows visitors to bring products for personal health use, such as medicines, food supplements, antiseptics, cosmetics, medical devices, etc., for personal use during their stay. However, visitors are required to bring just enough of each product to cover their needs during their stay and hold a letter from their doctor stating the medication(s) they are carrying.

Overall, it is essential to research and understand the regulations of the destination country regarding the importation of medical cannabis before travelling. The Sanskara Platform’s table of information provides a valuable resource for individuals travelling to popular British holiday destinations with medical cannabis needs.

View Travel Guide

TRAVEL ABROAD

WE ARE REGULARLY UPDATING OUR SITE

Travel Abroad With Medical Cannabis

Happy travels and stay safe!

The Cannabis Pages Logo

View The Medical Cannabis Directory

Your Guide to Importing Medical Cannabis on Your Next Holiday Read More »

The Sanskara Platform Joins Forces With The Cannabis Industry Council To Improve Patient Outcomes In The Medical Cannabis Industry

For Immediate Release – 06/02/2023

The Sanskara Platform Ltd. is proud to announce its membership with the Cannabis Industry Council (CIC), the leading organisation representing the UK cannabis sector. With over 100 members covering the entire cannabis supply chain and other industry stakeholders, the CIC is dedicated to improving access to medical cannabis and growing the CBD and hemp markets.

As a patient-led medical cannabis education platform, Sanskara is committed to advancing the medical cannabis industry through education and engagement. The platform offers a range of services, including consultancy, research, and advocacy, to support both patients and industry professionals. With a deep understanding of the medical cannabis community, Sanskara is bridging the gap between patients and the industry to drive positive change and improve patient outcomes.

“We’re thrilled to join forces with the Cannabis Industry Council and share their vision for improving access to cannabis for better health, the environment, and the economy,” said Mohammad Wasway, spokesperson for Sanskara. “As active members of the Council, we look forward to contributing to the development of solutions for the sector and advancing our mission to improve patient outcomes in the medical cannabis industry.“

Cannabis Industry Council CEO Mike Morgan-Giles also expressed his excitement about the new partnership, “The medical cannabis industry faces many regulatory and policy challenges, and we’re delighted to welcome Sanskara to the CIC. Their decision to join us highlights the growing recognition of the CIC across the sector, and we look forward to their contributions in developing solutions for the industry.“

As a member of the CIC, Sanskara will have access to a range of membership benefits, including participation in working groups, event attendance and networking, training, and representation with the government. The CIC’s goal is to raise the profile of the cannabis sector, improve access to medical cannabis, and help grow the CBD and hemp markets.

Join Sanskara and the Cannabis Industry Council in their mission to improve patient outcomes in the medical cannabis industry.

About The Sanskara Platform Ltd

The Sanskara Platform Ltd is a patient-led medical cannabis education platform dedicated to advancing the medical cannabis industry through education and engagement. The platform offers a range of services, including consultancy, research, and advocacy, to support both patients and industry professionals. With a deep understanding of the medical cannabis community, Sanskara is bridging the gap between patients and the industry to drive positive change and improve patient outcomes.

About the Cannabis Industry Council

The Cannabis Industry Council is the leading membership organisation for the entire UK cannabis sector, representing over 100 members covering the entire cannabis supply chain and other industry stakeholders. The CIC is dedicated to improving access to medical cannabis and growing the CBD and hemp markets.

Contact Information: For further information, please contact: mail@thesanskaraplatform.co.uk

The Sanskara Platform Joins Forces With The Cannabis Industry Council To Improve Patient Outcomes In The Medical Cannabis Industry Read More »

Understanding Cannabis Prescriptions w/ Prof. Mike Barnes

The Sanskara Platform asks Professor Mike Barnes questions to understand about Irradiation, The Entourage Effect and Certificate of Analysis, how it is effecting medical cannabis patients in the UK and how we can make improvements from what we understand.

> Irradiation (Is it necessary?, What are the pros and cons?, What are the regulations around it and what do they mean?)

> Entourage Effect (Is it a myth? How can we test it? What can be done to identify it?)

> CoAs (The importance of a CoA, Can and should patients access them? How can we understand them?)

> Patient Rights (Should doctors be informing patients of their rights? What do patients need to know? Can clinics provide forms of ID/Verification to reassure patients, landlords, employers, venue security/management and the police?)

> Clinics/Clinicians (Should clinics be deciding what the doctors prescribe? What can be done to ensure patients have access to all/any products available on the medical cannabis market? Will we see a platform for doctors and patients to access a product directory and live stock updates?)

Understanding Cannabis Prescriptions w/ Prof. Mike Barnes Read More »

Scroll to Top
Skip to content